Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Taliglucerase alfa"'
Autor:
Paskal Cullufi, Sonila Tomori, Virtut Velmishi, Agim Gjikopulli, Ilir Akshija, Aferdita Tako, Ermira Dervishi, Gladiola Hoxha, Marjeta Tanka, Erjon Troja, Mirela Tabaku
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
IntroductionEnzyme replacement therapy is already recognized as the gold standard of care for patients with Gaucher disease. Taliglucerase alfa is one of the three alternatives recommended for treatment of Gaucher disease in children and adults.AimTh
Externí odkaz:
https://doaj.org/article/5b59ef8b67cb46379e3cfb388e274ee5
Autor:
Lina Titievsky, Tilman Schuster, Ronnie Wang, Muhammad Younus, Andrew Palladino, Kabir Quazi, Michael P. Wajnrajch, Betina Hernandez, Pamela S. Becker, Neal J. Weinreb, Christina Chambers, Roy Mansfield, Louise Taylor, Li-Jung Tseng, Paige Kaplan
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background Limited real-world data from routine clinical care are available on the safety and effectiveness of treatment with taliglucerase alfa in patients with Gaucher disease (GD). Methods Taliglucerase Alfa Surveillance (TALIAS), a multi
Externí odkaz:
https://doaj.org/article/a2312ba99d1246d0b5b5524f11be215f
Autor:
Livia d’Avila Paskulin, Rodrigo Tzovenos Starosta, Filippo Pinto e Vairo, Bárbara C. Krug, Paulo Picon, Ida Vanessa Doederlein Schwartz
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 10 (2022)
Abstract Gaucher disease (GD) is one of the most common lysosomal disorders, occurring in approximately 1 in 40,000 live births worldwide. Since 2014 enzyme replacement therapy (ERT) with taliglucerase alfa has been the treatment of choice for adult
Externí odkaz:
https://doaj.org/article/6e25cdc749424aecb826f4a6e4309ed6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gupta P, Pastores GM
Publikováno v:
Pediatric Health, Medicine and Therapeutics, Vol Volume 8, Pp 73-81 (2017)
Punita Gupta,1 Gregory M Pastores2 1Division of Genetics, Department of Pediatrics, St. Joseph’s Children’s Hospital, Paterson, New Jersey, USA; 2National Center for Inherited Metabolic Disorders, Mater Misericordiae University Hospital, Universi
Externí odkaz:
https://doaj.org/article/0031ba34cb6f42b3942f2ca91891fc50
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Puna Maya Maharjan, Sunghwa Choe
Publikováno v:
Vaccines
Vaccines, Vol 9, Iss 992, p 992 (2021)
Vaccines, Vol 9, Iss 992, p 992 (2021)
The prevalence of the coronavirus disease 2019 (COVID-19) pandemic in its second year has led to massive global human and economic losses. The high transmission rate and the emergence of diverse SARS-CoV-2 variants demand rapid and effective approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::416a49bdf605e71b8443146e93b5fe4e
https://pubmed.ncbi.nlm.nih.gov/34579229
https://pubmed.ncbi.nlm.nih.gov/34579229
Autor:
Punita Gupta, Gregory M. Pastores
Publikováno v:
Pediatric Health, Medicine and Therapeutics
Gaucher disease (GD) is a heritable storage disorder caused by functional defects of the lysosomal acid β-glucosidase and the accumulation of glucosylceramide within macrophages, resulting in multiple organ dysfunction. There are three commercially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f17918ce9fd4ead8580bd286d71e4a
http://europepmc.org/articles/PMC5774592
http://europepmc.org/articles/PMC5774592
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-10 (2018)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Taliglucerase alfa is an enzyme replacement therapy (ERT) approved for treatment of adult and paediatric patients with Type 1 Gaucher disease (GD) in several countries and the first plant cell–expressed recombinant therapeutic protein approved by t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5783856b30b3e37cc33a51aae313d6b
http://link.springer.com/article/10.1186/s13023-018-0776-8
http://link.springer.com/article/10.1186/s13023-018-0776-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.